Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹8,081 Cr
up ₹444 Cr vs Feb 2025
- Stocks held
- 36
- unchanged
- Top 10 weight
- 60.2%
- of the portfolio in its ten largest
- Cash & debt
- 0.5%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 7
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In March 2025 it disclosed 36 stocks worth ₹8,081 Cr, up ₹444 Cr from Feb 2025. Its largest positions were Sun Pharmaceutical Industries Limited (13.4%), Divi's Laboratories Limited (9.3%), Lupin Limited (7.3%); the ten largest together made up 60.2% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 77.1% of its equity. Cash and debt stood at 0.5%. Compared with Feb 2025 the fund entered 0 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
85%
Top-10 weight is higher than 85% of peers
Breadth
31%
Holds more stocks than 31% of peers
Cash
7%
Holds more cash than 7% of peers
Holdings in March 2025
Download CSVEvery line the fund disclosed, with the change against Feb 2025. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 13.43%
- Δ weight
- down 0.25 pts
- Value
- ₹1,085 Cr
- Δ value
- up ₹40.7 Cr
- Status
- Added
- Weight
- 9.28%
- Δ weight
- down 0.04 pts
- Value
- ₹750 Cr
- Δ value
- up ₹38.3 Cr
- Status
- Added
- Weight
- 7.27%
- Δ weight
- down 0.45 pts
- Value
- ₹588 Cr
- Δ value
- down ₹2.4 Cr
- Status
- Held
- Weight
- 5.71%
- Δ weight
- down 0.19 pts
- Value
- ₹462 Cr
- Δ value
- up ₹11.1 Cr
- Status
- Added
- Weight
- 5.31%
- Δ weight
- up 0.17 pts
- Value
- ₹429 Cr
- Δ value
- up ₹36.6 Cr
- Status
- Added
- Weight
- 5.19%
- Δ weight
- down 0.17 pts
- Value
- ₹419 Cr
- Δ value
- up ₹10.1 Cr
- Status
- Added
- Weight
- 3.61%
- Δ weight
- up 0.33 pts
- Value
- ₹291 Cr
- Δ value
- up ₹41 Cr
- Status
- Added
- Weight
- 3.53%
- Δ weight
- up 0.12 pts
- Value
- ₹285 Cr
- Δ value
- up ₹24.8 Cr
- Status
- Added
- Weight
- 3.46%
- Δ weight
- down 0.36 pts
- Value
- ₹279 Cr
- Δ value
- down ₹12.4 Cr
- Status
- Trimmed
- Weight
- 3.41%
- Δ weight
- up 0.02 pts
- Value
- ₹276 Cr
- Δ value
- up ₹16.5 Cr
- Status
- Added
- Weight
- 3.11%
- Δ weight
- down 0.01 pts
- Value
- ₹252 Cr
- Δ value
- up ₹13.1 Cr
- Status
- Added
- Weight
- 3.01%
- Δ weight
- down 0.10 pts
- Value
- ₹244 Cr
- Δ value
- up ₹6.1 Cr
- Status
- Added
- Weight
- 2.99%
- Δ weight
- up 0.15 pts
- Value
- ₹241 Cr
- Δ value
- up ₹24.5 Cr
- Status
- Added
- Weight
- 2.45%
- Δ weight
- up 0.09 pts
- Value
- ₹198 Cr
- Δ value
- up ₹17.4 Cr
- Status
- Added
- Weight
- 2.19%
- Δ weight
- down 0.10 pts
- Value
- ₹177 Cr
- Δ value
- up ₹2 Cr
- Status
- Added
- Weight
- 2.18%
- Δ weight
- up 1.30 pts
- Value
- ₹176 Cr
- Δ value
- up ₹109 Cr
- Status
- Added
- Weight
- 2.01%
- Δ weight
- up 0.07 pts
- Value
- ₹162 Cr
- Δ value
- up ₹14.1 Cr
- Status
- Added
- Weight
- 2.01%
- Δ weight
- down 0.14 pts
- Value
- ₹162 Cr
- Δ value
- down ₹2.1 Cr
- Status
- Trimmed
- Weight
- 1.96%
- Δ weight
- up 0.27 pts
- Value
- ₹158 Cr
- Δ value
- up ₹29.1 Cr
- Status
- Added
- Weight
- 1.95%
- Δ weight
- up <0.01 pts
- Value
- ₹157 Cr
- Δ value
- up ₹8.7 Cr
- Status
- Added
- Weight
- 1.63%
- Δ weight
- up 0.12 pts
- Value
- ₹132 Cr
- Δ value
- up ₹16.4 Cr
- Status
- Added
- Weight
- 1.58%
- Δ weight
- down 0.11 pts
- Value
- ₹127 Cr
- Δ value
- down ₹1.5 Cr
- Status
- Trimmed
- Weight
- 1.49%
- Δ weight
- down 0.10 pts
- Value
- ₹120 Cr
- Δ value
- down ₹1.4 Cr
- Status
- Trimmed
- Weight
- 1.46%
- Δ weight
- up 0.07 pts
- Value
- ₹118 Cr
- Δ value
- up ₹11.5 Cr
- Status
- Added
- Weight
- 1.35%
- Δ weight
- up 0.13 pts
- Value
- ₹109 Cr
- Δ value
- up ₹15.7 Cr
- Status
- Added
- Weight
- 1.28%
- Δ weight
- up <0.01 pts
- Value
- ₹103 Cr
- Δ value
- up ₹5.9 Cr
- Status
- Added
- Weight
- 1.02%
- Δ weight
- down 0.07 pts
- Value
- ₹82.2 Cr
- Δ value
- down ₹1.2 Cr
- Status
- Trimmed
- Weight
- 1.01%
- Δ weight
- up 0.05 pts
- Value
- ₹81.7 Cr
- Δ value
- up ₹8.3 Cr
- Status
- Added
- Weight
- 0.97%
- Δ weight
- up 0.06 pts
- Value
- ₹78.1 Cr
- Δ value
- up ₹9 Cr
- Status
- Added
- Weight
- 0.95%
- Δ weight
- down 0.37 pts
- Value
- ₹77.1 Cr
- Δ value
- down ₹24.3 Cr
- Status
- Trimmed
- Weight
- 0.68%
- Δ weight
- up 0.12 pts
- Value
- ₹55.2 Cr
- Δ value
- up ₹12.2 Cr
- Status
- Added
- Cash, TREPS & receivables
- Weight
- 0.54%
- Δ weight
- down 0.57 pts
- Value
- ₹44 Cr
- Δ value
- down ₹40.9 Cr
- Status
- Trimmed
- Weight
- 0.53%
- Δ weight
- up 0.06 pts
- Value
- ₹42.7 Cr
- Δ value
- up ₹6.7 Cr
- Status
- Added
- Weight
- 0.47%
- Δ weight
- down 0.15 pts
- Value
- ₹38.2 Cr
- Δ value
- down ₹9.1 Cr
- Status
- Trimmed
- Weight
- 0.40%
- Δ weight
- up 0.01 pts
- Value
- ₹32.4 Cr
- Δ value
- up ₹2.9 Cr
- Status
- Added
- Weight
- 0.37%
- Δ weight
- up 0.05 pts
- Value
- ₹29.5 Cr
- Δ value
- up ₹5.5 Cr
- Status
- Added
- Weight
- 0.23%
- Δ weight
- up 0.01 pts
- Value
- ₹18.8 Cr
- Δ value
- up ₹2.1 Cr
- Status
- Added
What changed, Feb 2025 to Mar 2025
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Dr. Lal Path Labs Limitedup ₹109 Cr (+1.30% pts)
- GlaxoSmithKline Pharmaceuticals Limitedup ₹41 Cr (+0.33% pts)
- Sun Pharmaceutical Industries Limitedup ₹40.7 Cr (−0.25% pts)
- Divi's Laboratories Limitedup ₹38.3 Cr (−0.04% pts)
- Apollo Hospitals Enterprise Limited
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Feb 2025, the weight rose most in Healthcare Services (+1.2 pts), and fell most in Pharmaceuticals & Biotechnology (−1.2 pts).
- Healthcare Services17.7% → 18.9%+1.2 pts
- Pharmaceuticals & Biotechnology78.3% → 77.1%−1.2 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Mar 2022 | Mar 2024 | Sep 2024 | Dec 2024 | Feb 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 76.8% | 79.4% | 79.0% | 76.8% | 78.3% | 77.1% |
| Healthcare Services | 20.8% | 16.7% | 17.8% | 19.1% | 17.7% | 18.9% |
| Retailing | — | 3.1% | 2.4% | 3.4% | 3.4% | 3.4% |
| Pharmaceuticals | 1.8% | 0.9% | 0.8% | 0.7% | 0.5% | 0.5% |
Allocation in Mar 2025change vs Feb 2025
- Pharmaceuticals & Biotechnology (25)77.1%▼ 1.2 pts
- Healthcare Services (9)18.9%▲ 1.2 pts
- Retailing (1)3.4%
- Pharmaceuticals (1)
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Mar 2025
0.5%
▼ 0.6 pts vs Feb 2025
- Cash alone
- 0.5%
- cash and net receivables
- A year earlier
- 1.4%
- Mar 2024 · now ▼ 0.9 pts
- Last 12 months
- 0.5% – 4.4%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.